219 related articles for article (PubMed ID: 3542195)
1. Discrimination between benign and malignant cells of melanocytic lineage by two novel antigens, a glycoprotein with a molecular weight of 113,000 and a protein with a molecular weight of 76,000.
Lehmann JM; Holzmann B; Breitbart EW; Schmiegelow P; Riethmüller G; Johnson JP
Cancer Res; 1987 Feb; 47(3):841-5. PubMed ID: 3542195
[TBL] [Abstract][Full Text] [Related]
2. Antigenic profile of tumor progression stages in human melanocytic nevi and melanomas.
Elder DE; Rodeck U; Thurin J; Cardillo F; Clark WH; Stewart R; Herlyn M
Cancer Res; 1989 Sep; 49(18):5091-6. PubMed ID: 2548711
[TBL] [Abstract][Full Text] [Related]
3. Surface antigens of melanomas and melanocytes defined by mouse monoclonal antibodies: specificity analysis and comparison of antigen expression in cultured cells and tissues.
Real FX; Houghton AN; Albino AP; Cordon-Cardo C; Melamed MR; Oettgen HF; Old LJ
Cancer Res; 1985 Sep; 45(9):4401-11. PubMed ID: 4028024
[TBL] [Abstract][Full Text] [Related]
4. Phenotyping of lesions of melanocyte origin with monoclonal antibodies to melanoma-associated antigens and to HLA antigens.
Natali PG; Bigotti A; Cavaliere R; Nicotra MR; Ferrone S
J Natl Cancer Inst; 1984 Jul; 73(1):13-24. PubMed ID: 6376904
[TBL] [Abstract][Full Text] [Related]
5. Cross-reactivity of murine anti-human high molecular weight-melanoma associated antigen monoclonal antibodies with guinea pig melanoma cells.
Liao SK; Smith JW; Kwong PC; Natali PG; Kusama M; Hamby CV; Ferrone S
Cancer Res; 1987 Sep; 47(18):4835-41. PubMed ID: 3476198
[TBL] [Abstract][Full Text] [Related]
6. A new Mr 55,000 surface protein implicated in melanoma progression: association with a metastatic phenotype.
Boukerche H; Baril P; Tabone E; Bérard F; Sanhadji K; Balme B; Wolf F; Perrot H; Thomas L
Cancer Res; 2000 Oct; 60(20):5848-56. PubMed ID: 11059782
[TBL] [Abstract][Full Text] [Related]
7. A monoclonal antibody specific for cells of the melanocyte lineage.
Vennegoor C; Hageman P; Van Nouhuijs H; Ruiter DJ; Calafat J; Ringens PJ; Rümke P
Am J Pathol; 1988 Jan; 130(1):179-92. PubMed ID: 3276209
[TBL] [Abstract][Full Text] [Related]
8. Analysis with monoclonal antibodies of the molecular and cellular heterogeneity of human high molecular weight melanoma associated antigen.
Ziai MR; Imberti L; Nicotra MR; Badaracco G; Segatto O; Natali PG; Ferrone S
Cancer Res; 1987 May; 47(9):2474-80. PubMed ID: 3552215
[TBL] [Abstract][Full Text] [Related]
9. Identification of a secreted Mr 95,000 glycoprotein in human melanocytes and melanomas by a melanocyte specific monoclonal antibody.
Vogel AM; Esclamado RM
Cancer Res; 1988 Mar; 48(5):1286-94. PubMed ID: 3342407
[TBL] [Abstract][Full Text] [Related]
10. Mouse monoclonal antibody (FKH1) detecting human melanoma-associated antigens.
Fukaya T; Hashimoto K; Eto H; Mehregan A
Cancer Res; 1986 Oct; 46(10):5195-200. PubMed ID: 3756874
[TBL] [Abstract][Full Text] [Related]
11. Structural properties and tissue distribution of the antigen recognized by the monoclonal antibody 653.40S to human melanoma cells.
Natali PG; Imai K; Wilson BS; Bigotti A; Cavaliere R; Pellegrino MA; Ferrone S
J Natl Cancer Inst; 1981 Sep; 67(3):591-601. PubMed ID: 6944531
[TBL] [Abstract][Full Text] [Related]
12. Detection of malignant melanoma with monoclonal antibodies.
Saxton RE; Burke MW; Torbett B; Fairhurst M; Morton DL; Cochran AJ
Dis Markers; 1988 Jun; 6(2):97-108. PubMed ID: 3042264
[TBL] [Abstract][Full Text] [Related]
13. A 94,000-dalton glycoprotein expressed by human melanoma and carcinoma cells.
Imai K; Wilson BS; Bigotti A; Natali PG; Ferrone S
J Natl Cancer Inst; 1982 May; 68(5):761-9. PubMed ID: 6951087
[TBL] [Abstract][Full Text] [Related]
14. The differential reactivity of cells of the melanocytic lineage with four monoclonal antibodies against IFN-gamma inducible molecules.
Vacca A; Frassanito A; Rimoldi D; Dammacco F; Carrel S
Anticancer Res; 1992; 12(1):1-9. PubMed ID: 1348919
[TBL] [Abstract][Full Text] [Related]
15. Tissue distribution, molecular profile, and shedding of a cytoplasmic antigen identified by the monoclonal antibody 465.12S to human melanoma cells.
Natali PG; Wilson BS; Imai K; Bigotti A; Ferrone S
Cancer Res; 1982 Feb; 42(2):583-9. PubMed ID: 6173115
[TBL] [Abstract][Full Text] [Related]
16. Surface antigenic profile of uveal melanoma lesions analysed with a panel of monoclonal antibodies directed against cutaneous melanoma.
Carrel S; Schreyer M; Gross N; Zografos L
Anticancer Res; 1990; 10(1):81-9. PubMed ID: 1692197
[TBL] [Abstract][Full Text] [Related]
17. Development of MoAb HMSA-2 for melanosomes of human melanoma and its application to immunohistopathologic diagnosis of neoplastic melanocytes.
Maeda K; Jimbow K
Cancer; 1987 Feb; 59(3):415-23. PubMed ID: 3539311
[TBL] [Abstract][Full Text] [Related]
18. Development and characterization of a mouse monoclonal antibody, MoAb HMSA-1, against a melanosomal fraction of human malignant melanoma.
Akutsu Y; Jimbow K
Cancer Res; 1986 Jun; 46(6):2904-11. PubMed ID: 3516387
[TBL] [Abstract][Full Text] [Related]
19. [Mouse monoclonal antibody (FKH1) detecting human melanoma-associated antigens: production, partial characterization and immunohistochemical analysis].
Fukaya T
Hokkaido Igaku Zasshi; 1991 May; 66(3):300-10. PubMed ID: 1885156
[TBL] [Abstract][Full Text] [Related]
20. Tissue distribution, immunochemical characterization, and biosynthesis of 47D10, a tumor-associated surface glycoprotein.
Ho MK; Kato KP; Durda PJ; Murray JH; Wolfe H; Rabin H; Carney WP
Cancer Res; 1987 Jan; 47(1):241-50. PubMed ID: 3539319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
